Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2008

01-12-2008 | Research Article

Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital

Authors: Markus L. Lampert, Stephan Kraehenbuehl, Balthasar L. Hug

Published in: International Journal of Clinical Pharmacy | Issue 6/2008

Login to get access

Abstract

Aim To evaluate the Pharmaceutical Care Network Europe (PCNE) classification system as a tool for documenting the impact of a hospital clinical pharmacology service. Setting Two medical wards comprising totally 85 beds in a university hospital. Main outcome measure Number of events classified with the PCNE-system, their acceptance by the medical staff and cost implications. Methods Clinical pharmacy review of pharmacotherapy on ward rounds and from case notes were documented, and identified drug-related problems (DRPs) were classified using the PCNE system version 5.00. Results During 70 observation days 216 interventions were registered of which 213 (98.6%) could be classified: 128 (60.1%) were detected by reviewing the case notes, 33 (15.5%) on ward rounds, 32 (15.0%) by direct reporting to the clinical pharmacist (CP), and 20 (9.4%) on non-formulary prescriptions. Of 148 suggested interventions by the CP 123 (83.0%) were approved by the responsible physician, 12 ADR reports (8.1%) were submitted to the local pharmacovigilance centre and 31 (20.9%) specific information given without further need for action. An evaluation of the DRPs showed that direct drug costs of €2,058 within the study period or €10,731 per year could be avoided. Conclusion We consider the PCNE system to be a practical tool in the hospital setting, which demonstrates the values of a clinical pharmacy service in terms of identifying and reducing DRPs and also has the potential to reduce prescribing costs.
Literature
1.
go back to reference Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug related problems in hospitals—a review of the recent literature. Drug Saf. 2007;30:379–407.PubMedCrossRef Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug related problems in hospitals—a review of the recent literature. Drug Saf. 2007;30:379–407.PubMedCrossRef
2.
go back to reference Schlienger RG, Luescher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;3:110–5.CrossRef Schlienger RG, Luescher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;3:110–5.CrossRef
3.
go back to reference Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161–7.PubMed Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161–7.PubMed
4.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care—a systematic review. Arch Intern Med. 2006;166:955–64.PubMedCrossRef Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care—a systematic review. Arch Intern Med. 2006;166:955–64.PubMedCrossRef
5.
go back to reference Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. 2002 Task force on economic evaluation of clinical pharmacy services of the American College of Clinical Pharmacy. Pharmacotherapy. 2003;23:113–32.PubMedCrossRef Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. 2002 Task force on economic evaluation of clinical pharmacy services of the American College of Clinical Pharmacy. Pharmacotherapy. 2003;23:113–32.PubMedCrossRef
6.
go back to reference Ferner RE, Aronson JK. Clarification of terminology in medication errors. Drug Saf. 2006;29:1011–22.PubMedCrossRef Ferner RE, Aronson JK. Clarification of terminology in medication errors. Drug Saf. 2006;29:1011–22.PubMedCrossRef
9.
go back to reference Van Mil F, Westerlund T, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.PubMedCrossRef Van Mil F, Westerlund T, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.PubMedCrossRef
10.
go back to reference Allenet B, Bedouch P, Rose FX, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28:181–8.PubMedCrossRef Allenet B, Bedouch P, Rose FX, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28:181–8.PubMedCrossRef
11.
go back to reference AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment related problems. Pharm Word Sci. 2006;28:222–32.CrossRef AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment related problems. Pharm Word Sci. 2006;28:222–32.CrossRef
12.
go back to reference Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.PubMedCrossRef Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.PubMedCrossRef
13.
go back to reference Lagler M, editor. Arzneimittelkompendium der Schweiz. 2007. 28th ed. (ISBN 3–85640–313–2), Basel: Documed; 2006. Lagler M, editor. Arzneimittelkompendium der Schweiz. 2007. 28th ed. (ISBN 3–85640–313–2), Basel: Documed; 2006.
14.
go back to reference Hatoum HT, Hutchinson RA, Elliott LR, Kendzierski DL. Physicians’ review of significant interventions by clinical pharmacists in inpatient care. Drug Intell Clin Pharm. 1988;22:980–2.PubMed Hatoum HT, Hutchinson RA, Elliott LR, Kendzierski DL. Physicians’ review of significant interventions by clinical pharmacists in inpatient care. Drug Intell Clin Pharm. 1988;22:980–2.PubMed
15.
go back to reference Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharm. 2004;57:513–21.CrossRef Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharm. 2004;57:513–21.CrossRef
16.
go back to reference Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.PubMed Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.PubMed
17.
go back to reference Ganso M. Documentation and analysis of pharmaceutical interventions, 6. Konstanzer Apothekerkolloquium. 2006. (Oral Communication). Ganso M. Documentation and analysis of pharmaceutical interventions, 6. Konstanzer Apothekerkolloquium. 2006. (Oral Communication).
18.
go back to reference Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–6.PubMed Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–6.PubMed
19.
go back to reference Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.PubMedCrossRef Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.PubMedCrossRef
20.
go back to reference McMullin ST, Hennenfelt JA, Bailey TC, et al. A prospective, randomized trial to assess the cost of pharmacist-initiated interventions. Arch Int Med. 1999;159:2306–9.CrossRef McMullin ST, Hennenfelt JA, Bailey TC, et al. A prospective, randomized trial to assess the cost of pharmacist-initiated interventions. Arch Int Med. 1999;159:2306–9.CrossRef
21.
go back to reference Croft Buck T, Brandstru L, Brandslund I, Kampmann JP. The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark. Pharm World Sci. 2007;29:12–8.CrossRef Croft Buck T, Brandstru L, Brandslund I, Kampmann JP. The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark. Pharm World Sci. 2007;29:12–8.CrossRef
22.
go back to reference Ruettimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348–56.CrossRef Ruettimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348–56.CrossRef
23.
go back to reference Bajcar J, Chin T, Chui W, Wichman K. Development of a comprehensive clinical pharmacy workload documentation system. Can J Hosp Pharm. 1995;48:80–9.PubMed Bajcar J, Chin T, Chui W, Wichman K. Development of a comprehensive clinical pharmacy workload documentation system. Can J Hosp Pharm. 1995;48:80–9.PubMed
Metadata
Title
Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital
Authors
Markus L. Lampert
Stephan Kraehenbuehl
Balthasar L. Hug
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9213-8

Other articles of this Issue 6/2008

International Journal of Clinical Pharmacy 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.